Status:
COMPLETED
Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris
Lead Sponsor:
Sebacia, Inc.
Conditions:
Acne Vulgaris
Eligibility:
All Genders
16-35 years
Phase:
NA
Brief Summary
Prospective, multicenter study with multiple arms to examine the safety and effectiveness of the Sebacia Acne Treatment System for the treatment of acne vulgaris.
Eligibility Criteria
Inclusion
- clinical diagnosis of moderate to severe acne vulgaris
Exclusion
- use of oral retinoid therapy in the past 12 months
- pregnancy, lactating, or planning to become pregnant
- excessive scarring in the treatment area, or other condition that would impact the ability to evaluate acne
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT02219074
Start Date
June 1 2011
End Date
October 1 2016
Last Update
September 7 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Specjalistyczny Gabinet Dermatologiczny
Krakow, Poland, 31-530
2
Military Institute of Health Services
Warsaw, Poland, 04-141